1. Home
  2. MAIA vs PODC Comparison

MAIA vs PODC Comparison

Compare MAIA & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • PODC
  • Stock Information
  • Founded
  • MAIA 2018
  • PODC 2013
  • Country
  • MAIA United States
  • PODC United States
  • Employees
  • MAIA N/A
  • PODC N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • PODC
  • Sector
  • MAIA Health Care
  • PODC
  • Exchange
  • MAIA Nasdaq
  • PODC Nasdaq
  • Market Cap
  • MAIA 46.7M
  • PODC 44.1M
  • IPO Year
  • MAIA 2022
  • PODC N/A
  • Fundamental
  • Price
  • MAIA $1.82
  • PODC $1.86
  • Analyst Decision
  • MAIA
  • PODC Strong Buy
  • Analyst Count
  • MAIA 0
  • PODC 1
  • Target Price
  • MAIA N/A
  • PODC $5.00
  • AVG Volume (30 Days)
  • MAIA 341.6K
  • PODC 22.0K
  • Earning Date
  • MAIA 05-09-2025
  • PODC 05-29-2025
  • Dividend Yield
  • MAIA N/A
  • PODC N/A
  • EPS Growth
  • MAIA N/A
  • PODC N/A
  • EPS
  • MAIA N/A
  • PODC N/A
  • Revenue
  • MAIA N/A
  • PODC $49,729,000.00
  • Revenue This Year
  • MAIA N/A
  • PODC $20.67
  • Revenue Next Year
  • MAIA N/A
  • PODC $19.09
  • P/E Ratio
  • MAIA N/A
  • PODC N/A
  • Revenue Growth
  • MAIA N/A
  • PODC 22.98
  • 52 Week Low
  • MAIA $1.40
  • PODC $1.10
  • 52 Week High
  • MAIA $5.99
  • PODC $2.85
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 47.29
  • PODC 50.86
  • Support Level
  • MAIA $1.80
  • PODC $1.80
  • Resistance Level
  • MAIA $2.18
  • PODC $2.11
  • Average True Range (ATR)
  • MAIA 0.29
  • PODC 0.20
  • MACD
  • MAIA -0.03
  • PODC -0.00
  • Stochastic Oscillator
  • MAIA 4.85
  • PODC 25.00

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.

Share on Social Networks: